Editorial: Discovery, development and implementation of improved options for treating opioid overdose in the synthetic opioid era
Christian Heidbreder,
Mark K. Greenwald,
Bernard Le Foll,
Phil Skolnick
Affiliations
Christian Heidbreder
Research & Development, Indivior, Inc., Chesterfield, VA, United States
Mark K. Greenwald
Department of Psychiatry and Behavioral Neurosciences, School of Medicine, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, United States
Bernard Le Foll
Translational Addiction Research Laboratory, Centre for Addiction and Mental Health, Toronto, ON, Canada
Phil Skolnick
Research & Development, Indivior, Inc., Chesterfield, VA, United States